Received May 6, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB064A | — |
Menveo expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 24-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB064A, expiry date 31-DEC-2025) for prophylaxis. On 29-APR-2026, the patient received Menveo. On 29-APR-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 29-APR-2026 The reporter consented to follow up. The vaccine administration facility was the same as primary reporter. The batch number was not provided upon follow- up with the reporter.